[HTML][HTML] New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia
S Amin, G Carling, L Gan - Current Opinion in Neurobiology, 2022 - Elsevier
Frontotemporal dementia (FTD) is the second most common form of dementia. It affects the
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …
New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia
S Amin, G Carling, L Gan - Current opinion in …, 2022 - pubmed.ncbi.nlm.nih.gov
Frontotemporal dementia (FTD) is the second most common form of dementia. It affects the
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …
New insights and therapeutic opportunities for progranulin-deficient frontotemporal dementia.
S Amin, G Carling, L Gan - Current Opinion in Neurobiology, 2021 - europepmc.org
Frontotemporal dementia (FTD) is the second most common form of dementia. It affects the
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …
frontal and temporal lobes of the brain and has a highly heterogeneous clinical …